Zhuhai HRD Pharm Co., Ltd.
Zhuhai HRD Pharm Co., Ltd., since its establishment in 2009, has grown into a modern pharmaceutical enterprise integrating the research and development, production, and sales of pharmaceutical raw materials and intermediates. The company has invested 250 million yuan in the construction of a GMP production base in the Gaolan Port National Chemical Industrial Park in Zhuhai, Guangdong, which was completed and put into operation in the second half of 2023, with an annual production capacity of 300 tons and an annual output value of over 1 billion yuan. HRD Pharm has 9 GMP workshops and more than 200 reactors, capable of meeting diverse production needs from pilot to scale-up.
-
2009Established in 2009
-
250
million
Investment of 250 million yuan -
300
tons
Annual production capacity of 300 tons -
10
billion
Annual output value exceeds 10 billion yuan
why choose us
Social responsibilities
The company adheres to the philosophy of safety compliance, innovative efficiency, pragmatic dedication, and win-win integrity, committed to safeguarding human health.
-
1
Practicing Social Responsibility
HRD Pharm also actively fulfills its corporate social responsibility by participating in public health projects, supporting health education, and disease prevention, contributing to societal health. -
2
Implementing Environmental Protection Measures
The company strictly follows environmental protection regulations in the production process, reducing the discharge of wastewater, exhaust gases, and waste slag. Additionally, the company has invested in advanced environmental protection facilities, such as sewage treatment plants and exhaust gas treatment devices, ensuring effective treatment of pollutants in the production process. -
3
Green Development
Furthermore, the company actively conducts research on green production technologies, such as recycling and energy saving, to achieve greening and sustainable development of the production process.

Corporate Vision
Through unremitting efforts, HRD Pharm is moving towards becoming a leading enterprise in the global pharmaceutical field, making greater contributions to the cause of human health and creating a better and healthier future.